← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Theranostec, Inc.
Carmichael, CA
$5,266,538
Total funding
5
Grants
Funding over time
peak $1.5M · FY2018–24$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,266,538 · 5
By mechanism
R44$4,341,539 · 2
R43$924,999 · 3
Investigators at Theranostec, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Extremely long tumor retention, on-demand releasing Nano-Taxel for eradicating ovarian cancers$1,496,599
R44 · FY2020 · CA
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma$849,788
R44 · FY2023 · CA
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma$719,958
R44 · FY2024 · CA
Extremely long tumor retention, on-demand releasing Nano-Taxel for eradicating ovarian cancers$503,046
R44 · FY2019 · CA
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma$480,254
R44 · FY2021 · CA
Sub-100 nm and scalable self-therapeutic nanoparticles to target autophagy in pancreatic cancer$399,999
R43 · FY2022 · CA
Transformable nano-theranostics for image-guided interventions in head and neck squamous cell carcinoma$300,000
R43 · FY2019 · CA
Extremely long tumor retention, on-demand releasing Nano-Taxel for eradicating ovarian cancers$291,894
R44 · FY2018 · CA
Ninja Theranostics for overcoming the drug delivery barriers to pediatric brain tumor$225,000
R43 · FY2018 · HD